PMID- 37564231 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230812 IS - 0974-2727 (Print) IS - 0974-7826 (Electronic) IS - 0974-2727 (Linking) VI - 15 IP - 3 DP - 2023 Sep TI - Pathological Spectrum and beta-APP Immunoreactivity as a Diagnostic Tool of Diffuse Axonal Injury following Traumatic Brain Injury: A Novel Classification. PG - 399-408 LID - 10.1055/s-0043-1761926 [doi] AB - Aim Different deposition patterns and grading systems used to define and identify DAI remain discordant and to date these are a challenge in clinical practice. Our main objective was to study the post-mortem axonal changes and develop a grading system to identify DAI on the basis of histopathological and immunoreactive beta-amyloid precursor protein (beta-APP) observations in severe TBI cases. Methods Prospective study with 35 decedents with sTBI (GCS score